Paid Clinical Trials in Texas

Texas has 5,331 paid clinical trials enrolling now across cities including Houston, Dallas and San Antonio. Search by condition, age, or phase to find compensated research studies accepting participants near you.

Research sites in Texas include MD Anderson Cancer Center, Baylor College of Medicine and UT Southwestern, running studies across oncology, cardiology, neurology, and more. Both patients and healthy volunteers may qualify. Most studies offer compensation for time and travel.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: July 31, 2026.

Filter results

Filter results

State

City

Recruitment status

Phase

Study type

Intervention

Condition

Sex

Age

Healthy volunteers only

4,648 clinical trials

Safety, Pharmacokinetics (PK), and Efficacy of ONC 841 in Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston +7 more locations

Sponsor: OncoC4, Inc.

Sex: All·Age: 18+

Code: NCT06352359·Phase 1·Recruiting·Listed Apr 2024

Apply to this trial

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

for Acute Myeloid Leukemia

Sites in Houston +5 more locations

Sponsor: Daiichi Sankyo

Sex: All·Age: 18+

Code: NCT06824168·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Balance4Mobility: Effects of Walkasins Use in Individuals With Peripheral Neuropathy and Balance Problems

for Peripheral Neuropathies

Sites in Galveston +2 more locations

Sponsor: RxFunction Inc.

Sex: All·Age: 55+

Code: NCT06959277·Recruiting·Listed May 2025

Apply to this trial

SPI-1005 in Adults Receiving Cochlear Implant

for Hearing Loss

Sites in Dallas +5 more locations

Sponsor: Sound Pharmaceuticals, Incorporated

Sex: All·Age: 18+

Code: NCT06340633·Phase 2·Recruiting·Listed Apr 2024

Apply to this trial

A First-in-human, Dose Escalation and Dose Expansion Study of SAR445877 in Adult Participants With Advanced Solid Tumors

for Solid Tumor

Sites in Houston +8 more locations

Sponsor: Sanofi

Sex: All·Age: 18+

Code: NCT05584670·Phase 1, Phase 2·Recruiting·Listed Oct 2022

Apply to this trial

Study of BG-T187 Alone and in Combination With Other Therapeutic Agents in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston +3 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT06598800·Phase 1·Recruiting·Listed Sep 2024

Apply to this trial

A Study to Assess Adverse Events, How the Drug Moves Through the Body and Effectiveness of Intravenous Infusions of ABBV-319 in Adult Participants With Systemic Lupus Erythematosus (SLE) and Sjogren's Disease (SjD)

for Dry Eye Syndrome

Sites in Harlingen +3 more locations

Sponsor: AbbVie

Sex: All·Age: 18 - 75

Code: NCT06977724·Phase 1·Recruiting·Listed May 2025

Apply to this trial

Study of ISM3412 in Participants With Locally Advanced/Metastatic Solid Tumors

for Locally Advanced/Metastatic Solid Tumors

Sites in Houston +4 more locations

Sponsor: InSilico Medicine Hong Kong Limited

Sex: All·Age: 18+

Code: NCT06414460·Phase 1, Phase 2·Recruiting·Listed May 2024

Apply to this trial

FiH Study to Investigate Safety, PK and Efficacy of the NaPi2b ADC TUB-040 in Patients With PROC or r/r Adenocarcinoma NSCLC

for Ovarian Cancer

Sites in Irving +6 more locations

Sponsor: Tubulis GmbH

Sex: All·Age: 18+

Code: NCT06303505·Phase 1, Phase 2·Recruiting·Listed Mar 2024

Apply to this trial

Dose Escalation and Dose Expansion Study of MDX2001 in Patients With Advanced Solid Tumors

for Biliary Tract Cancer

Sites in Houston, San Antonio +4 more locations

Sponsor: ModeX Therapeutics, An OPKO Health Company

Sex: All·Age: 18+

Code: NCT06239194·Phase 1, Phase 2·Recruiting·Listed Feb 2024

Apply to this trial

Registry of Patients With AQP4+ NMOSD Treated With Alexion C5 Inhibitor Therapies

for Neuromyelitis Optica Spectrum Disorder

Sites in Plano +5 more locations

Sponsor: Alexion Pharmaceuticals, Inc.

Sex: All·Age: 18+

Code: NCT05966467·Recruiting·Listed Jul 2023

Apply to this trial

A First-In-Human, Phase 1 Study Evaluating Oral TACC3 PPI Inhibitor, AO-252, in Advanced Solid Tumors With or Without Brain Metastases

for Solid Tumor Malignancies

Sites in Houston, Dallas +4 more locations

Sponsor: A2A Pharmaceuticals Inc.

Sex: All·Age: 18+

Code: NCT06136884·Phase 1·Recruiting·Listed Nov 2023

Apply to this trial

NIBP Validation Study

for Critical Illness

Sites in San Antonio +2 more locations

Sponsor: Philips Clinical & Medical Affairs Global

Sex: All·Age: All ages

Code: NCT05673408·Recruiting·Listed Jan 2023

Apply to this trial

A Clinical Trial Comparing 2x/Day for 30-minutes Use of the Emanate Perio PODS Post-SRP to a Control Group Post-SRP.

for Periodontitis (Stage 3)

Sites in Houston, Spring +7 more locations

Sponsor: McGuire Institute

Sex: All·Age: 30 - 75

Code: NCT06914596·Recruiting·Listed Apr 2025

Apply to this trial

Safety and Tolerability of Subretinally Injected OPGx-BEST1 in Patients With Best Vitelliform Macular Dystrophy (BVMD) or Autosomal-Recessive Bestrophinopathy (ARB)

for ARB

Sites in Dallas +3 more locations

Sponsor: Opus Genetics, Inc

Sex: All·Age: 18+

Code: NCT07185256·Phase 1, Phase 2·Recruiting·Listed Sep 2025

Apply to this trial

Evaluation of ELU42 Topical Spray for the Treatment of Diabetic Foot Ulcers

for Diabetic Foot Ulcer

Sites in McAllen +3 more locations

Sponsor: Eluciderm Inc

Sex: All·Age: 18 - 75

Code: NCT07396376·Phase 1, Phase 2·Recruiting·Listed Feb 2026

Apply to this trial

A Study to Investigate Multiple Sclerosis Relapse Prevention With mRNA-1195 Compared With Placebo in Participants Aged 18 to ≤55 Years

for Multiple Sclerosis

Sites in Dallas, El Paso +4 more locations

Sponsor: ModernaTX, Inc.

Sex: All·Age: 18 - 55

Code: NCT06735248·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

HF158K1 in Patients With HER-2 Expressing Advanced Solid Tumors

for Solid Tumors, Adult

1 location in Dallas

Sponsor: HighField Biopharmaceuticals Corporation

Sex: All·Age: 18 - 75

Code: NCT05861895·Phase 1·Recruiting·Listed May 2023

Apply to this trial

A Study of Efgartigimod PH20 SC in Children Between 2 and Less Than 18 Years of Age With Generalized Myasthenia Gravis

for Generalized Myasthenia Gravis

Drug: Efgartigimod PH20 SC

Sites in Denton +2 more locations

Sponsor: argenx

Sex: All·Age: 2 - 17

Code: NCT06392386·Phase 2, Phase 3·Recruiting·Listed Apr 2024

Apply to this trial

CT-95 in Advanced Cancers Associated With Mesothelin Expression

for Mesothelin-Expressing Tumors

Sites in San Antonio +8 more locations

Sponsor: Context Therapeutics Inc.

Sex: All·Age: 18+

Code: NCT06756035·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A Study to Evaluate the Safety and Tolerability, Pharmacokinetics, and Antiviral Activity of Maribavir for the Treatment of Cytomegalovirus (CMV) Infection in Children and Adolescents Who Have Received a Hematopoietic Stem Cell Transplant (HSCT) or a Solid Organ Transplant (SOT)

for Cytomegalovirus (CMV)

Sites in Houston, Fort Worth +6 more locations

Sponsor: Takeda

Sex: All·Age: Up to 17

Code: NCT05319353·Phase 3·Recruiting·Listed Apr 2022

Apply to this trial

A Phase 1, First-in-human Study of OKN4395 and Pembrolizumab in Patients With Solid Tumors

for Solid Tumours

Sites in Houston +2 more locations

Sponsor: Epkin

Sex: All·Age: 18+

Code: NCT06789172·Phase 1·Recruiting·Listed Jan 2025

Apply to this trial

A First in Human Study of ALX2004 With Advanced or Metastatic Selected Solid Tumors

for NSCLC (Advanced Non-small Cell Lung Cancer)

Sites in Houston +7 more locations

Sponsor: ALX Oncology Inc.

Sex: All·Age: 18+

Code: NCT07085091·Phase 1·Recruiting·Listed Jul 2025

Apply to this trial

A Study of MGC028 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in San Antonio +6 more locations

Sponsor: MacroGenics

Sex: All·Age: 18+

Code: NCT06723236·Phase 1·Recruiting·Listed Dec 2024

Apply to this trial

A Study of Calderasib (MK-1084) in Participants With Hepatic Impairment and Healthy Volunteers (MK-1084-017)

for Healthy

Drug: Calderasib

Sites in San Antonio +2 more locations

Sponsor: Merck Sharp & Dohme LLC

Sex: All·Age: 18 - 80·Accepts healthy volunteers

Code: NCT07219550·Phase 1·Recruiting·Listed Oct 2025

Apply to this trial

PTM-101 in Pancreatic Ductal Adenocarcinoma (PDAC)

for Pancreatic Ductal Adenocarcinoma

Sites in Houston, Dallas +4 more locations

Sponsor: PanTher Therapeutics

Sex: All·Age: 18+

Code: NCT06673017·Phase 1·Recruiting·Listed Nov 2024

Apply to this trial

IKS014 in Advanced Solid Tumors That Express HER2

for Breast Cancer

Sites in Fort Worth +3 more locations

Sponsor: Iksuda Therapeutics Ltd.

Sex: All·Age: 18+

Code: NCT05872295·Phase 1·Recruiting·Listed May 2023

Apply to this trial

A First-in-Human (FIH) Study to Evaluate the Safety and Tolerability of VVD-130037 in Participants With Advanced Solid Tumors

for Advanced Solid Tumors

Sites in Houston, Irving +6 more locations

Sponsor: Vividion Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05954312·Phase 1·Recruiting·Listed Jul 2023

Apply to this trial

Evaluation of RBS2418 in Patients With Advanced, Metastatic, and Progressive Colorectal Cancer

for Metastatic Colorectal Cancer

Sites in Kingwood +1 more location

Sponsor: Riboscience, LLC.

Sex: All·Age: 18+

Code: NCT06824064·Phase 2·Recruiting·Listed Feb 2025

Apply to this trial

Study of FIH of STX-241 in Locally Advanced or Metastatic NSCLC Resistant to EGFR TKIs

for Non-small Cell Lung Cancer (NSCLC)

Sites in Houston +1 more location

Sponsor: Pierre Fabre Medicament

Sex: All·Age: 18+

Code: NCT06567015·Phase 1, Phase 2·Recruiting·Listed Aug 2024

Apply to this trial

Clinical Study of the inQB8 TTVR System (The MonarQ Study)

for Tricuspid Valve Regurgitation

Sites in Plano +5 more locations

Sponsor: inQB8 Medical Technologies, LLC

Sex: All·Age: 18+

Code: NCT06611579·Recruiting·Listed Sep 2024

Apply to this trial

A Study to Learn More About the Safety of BIIB145 and How it is Processed in the Body of Healthy Adult Participants

for Healthy Volunteer

1 location in Austin

Sponsor: Biogen

Sex: All·Age: 18 - 55·Accepts healthy volunteers

Code: NCT07225517·Phase 1·Recruiting·Listed Nov 2025

Apply to this trial

A Study to Evaluate the Safety and Tolerability of TOS-358 in Women With HR+ HER2- Breast Cancer

for HR+/HER2-negative Breast Cancer

Sites in Flower Mound +8 more locations

Sponsor: Totus Medicines

Sex: Female·Age: 18+

Code: NCT05683418·Phase 1·Recruiting·Listed Jan 2023

Apply to this trial

A Study to Understand How the Study Medicine Dazukibart Works in People With Idiopathic Inflammatory Myopathies

for Dermatomyositis

Sites in Houston, Allen +2 more locations

Sponsor: Pfizer

Sex: All·Age: 18+

Code: NCT06698796·Phase 3·Recruiting·Listed Nov 2024

Apply to this trial

A Study Investigating BGB-26808 Alone or in Combination With Tislelizumab in Participants With Advanced Solid Tumors

for Advanced Solid Tumor

Sites in Houston +8 more locations

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT05981703·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Safety, Pharmacokinetics, and Preliminary Efficacy of VIR-5500 (AMX-500) in Prostate Cancer

for Hormone-refractory Prostate Cancer

Sites in Houston +3 more locations

Sponsor: Vir Biotechnology, Inc.

Sex: Male·Age: 18+

Code: NCT05997615·Phase 1·Recruiting·Listed Aug 2023

Apply to this trial

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Breast Cancer w/Liver Dominant Disease

for Metastatic Breast Cancer in the Liver

Sites in Dallas +3 more locations

Sponsor: Delcath Systems Inc.

Sex: All·Age: 18+

Code: NCT06875128·Phase 2·Recruiting·Listed Mar 2025

Apply to this trial

A Study of Lorigerlimab in Participants With Advanced Solid Tumors

for Platinum-resistant Ovarian Cancer

Sites in Houston, San Antonio +5 more locations

Sponsor: MacroGenics

Sex: Female·Age: 18+

Code: NCT06730347·Phase 2·Recruiting·Listed Dec 2024

Apply to this trial

A Phase 1/2a Study of DB-2304 in Healthy Adults and SLE/CLE Participants

for Systemic Lupus Erythematosus (SLE) or Cutaneous Lupus Erythematosus

Sites in San Antonio, Irving +4 more locations

Sponsor: DualityBio Inc.

Sex: All·Age: 18 - 70·Accepts healthy volunteers

Code: NCT06625671·Phase 1, Phase 2·Recruiting·Listed Oct 2024

Apply to this trial

PReSeRVE-HD: Observational Study of the Merit HeRO® Graft and Super HeRO® in Patients on Hemodialysis

for End Stage Renal Disease

Sites in Houston, Dallas +5 more locations

Sponsor: Merit Medical Systems, Inc.

Sex: All·Age: 18+

Code: NCT06422871·Recruiting·Listed May 2024

Apply to this trial